Tabula Rasa HealthCare, Inc.

Symbol: TRHC




Market price today

  • -4.3633

    P/E Ratio

  • 0.0234

    PEG Ratio

  • 284.03M

    MRK Cap

  • 0.00%

    DIV Yield

Tabula Rasa HealthCare, Inc. (TRHC) Stock Price & Analysis

Shares Outstanding


Gross Profit Margin


Operating Profit Margin


Net Profit Margin


Return on Assets


Return on Equity


Return on Capital Employed


Company general description and statistics

Sector: Healthcare
Industry: Health Information Services
CEO:Mr. Brian W. Adams
Full-time employees:1027
Address:228 Strawbridge Drive

Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company operates in two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise medication therapy management software, a cloud-based platform designed to aid in the identification and resolution of medication and health-related problems. The company also provides TruChart that offers electronic health records (EHR), care coordination, and financial management in one program allowing Programs of All-Inclusive Care for the Elderly (PACE) to track measurable outcomes in defined timeframes for the populations they serve; and PACElogic, which delivers sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination and planning, integration with community-based providers, and various federal and state that requires reporting. In addition, it offers DoseMeRx, a decision support software that leverages clinically validated pharmacokinetic drug models, patient characteristics, drug concentrations, and genotypes to guide dose optimization; and PrescribeWellness, a PrescribeWellness, a patient engagement center platform. Further, the company provides clinical pharmacist collaboration, prescription fulfillment and adherence packaging, and pharmacy benefit management services, as well as health plan management services, including risk adjustment and third party administrator services. As of December 31, 2021, it served approximately 150 healthcare organizations; and 350 health plans and approximately 18,000 retail pharmacies. The company provides cloud-based software applications to assist prescribers and pharmacists. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.

General Outlook

When we look at how much money they make before expenses, they keep 0.236% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.138%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.181%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.172% return, is a testament to Tabula Rasa HealthCare, Inc.'s adeptness in optimizing resource deployment. Tabula Rasa HealthCare, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 1.030%. Furthermore, the proficiency of Tabula Rasa HealthCare, Inc. in capital utilization is underscored by a remarkable -0.178% return on capital employed.

Liquidity Ratios

Analyzing TRHC liquidity ratios reveals its financial health of the firm. The current ratio of 156.56% gauges short-term asset coverage for liabilities. The quick ratio (108.19%) assesses immediate liquidity, while the cash ratio (67.04%) indicates cash reserves.

Current Ratio156.56%
Quick Ratio108.19%
Cash Ratio67.04%

Profitability Ratios

TRHC profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -17.99% underscores its earnings before tax deductions. The effective tax rate stands at -0.41%, revealing its tax efficiency. The net income per EBT, 100.59%, and the EBT per EBIT, 129.99%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -13.84%, we grasp its operational profitability.

Pretax Profit Margin-17.99%
Effective Tax Rate-0.41%
Net Income per EBT100.59%
EBT per EBIT129.99%
EBIT per Revenue-13.84%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 1.57, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations. Meanwhile, a 1 cash conversion cycle and 877.05% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

Days of Sales Outstanding108
Days of Inventory Outstanding12
Operating Cycle53.85
Days of Payables Outstanding29
Cash Conversion Cycle25
Receivables Turnover8.77
Payables Turnover12.52
Inventory Turnover29.83
Fixed Asset Turnover17.32
Asset Turnover0.95

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -0.20, and free cash flow per share, -0.94, depict cash generation on a per-share basis. The cash per share value, 2.47, showcases liquidity position. Lastly, the operating cash flow sales ratio, -0.02, offers insight into cash flow relative to sales.

Operating Cash Flow per Share-0.20
Free Cash Flow per Share-0.94
Cash per Share2.47
Operating Cash Flow Sales Ratio-0.02
Free Cash Flow to Operating Cash Flow Ratio4.68
Cash Flow Coverage Ratio-0.02
Short Term Coverage Ratio-1.72
Capital Expenditure Coverage Ratio-0.27
Dividend Paid and Capex Coverage Ratio-0.27

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 94.51%, highlights its total liabilities relative to assets. With a debt-equity ratio of -4.31, we discern the balance between debt and equity financing. The long-term debt to capitalization, 130.58%, and total debt to capitalization, 130.23%, ratios shed light on its capital structure. An interest coverage of -6.95 indicates its ability to manage interest expenses.

Debt Ratio94.51%
Debt Equity Ratio-4.31
Long Term Debt to Capitalization130.58%
Total Debt to Capitalization130.23%
Interest Coverage-6.95
Cash Flow to Debt Ratio-0.02
Company Equity Multiplier-4.56

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 12.33, provides a glimpse into top-line earnings distributed across each share. Net income per share, -3.18, reflects the portion of profit attributed to each share. The book value per share, -2.35, represents the net asset value distributed per share, while the tangible book value per share, -10.01, excludes intangible assets.

Revenue Per Share12.33
Net Income Per Share-3.18
Book Value Per Share-2.35
Tangible Book Value Per Share-10.01
Shareholders Equity Per Share-2.35
Interest Debt Per Share14.21
Capex Per Share-1.18

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -9.58%, indicates top-line expansion, while the gross profit growth, -31.65%, reveals profitability trends. EBIT growth, 18.67%, and operating income growth, 18.67%, offer insights into operational profitability progression. The net income growth, 2.18%, showcases bottom-line expansion, and the EPS growth, 6.19%, measures the growth in earnings per share.

Revenue Growth-9.58%
Gross Profit Growth-31.65%
EBIT Growth18.67%
Operating Income Growth18.67%
Net Income Growth2.18%
EPS Growth6.19%
EPS Diluted Growth6.19%
Weighted Average Shares Growth4.31%
Weighted Average Shares Diluted Growth4.31%
Operating Cash Flow Growth-52.39%
Free Cash Flow Growth-8.29%
10-Year Revenue Growth per Share383.27%
5-Year Revenue Growth per Share53.31%
3-Year Revenue Growth per Share-10.70%
10-Year Operating CF Growth per Share238.50%
5-Year Operating CF Growth per Share-72.33%
3-Year Operating CF Growth per Share207.40%
10-Year Net Income Growth per Share-710.46%
5-Year Net Income Growth per Share-472.54%
3-Year Net Income Growth per Share-102.39%
10-Year Shareholders Equity Growth per Share-44.42%
5-Year Shareholders Equity Growth per Share-132.06%
3-Year Shareholders Equity Growth per Share-126.09%
5-Year Dividend per Share Growth per Share-100.00%
Receivables Growth-21.36%
Inventory Growth20.61%
Asset Growth-23.08%
Book Value per Share Growth-198.06%
Debt Growth-9.82%
R&D Expense Growth-26.82%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 386,363,740.85, captures the company's total value, considering both debt and equity. Income quality, -0.05, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.25, gauges operational efficiency, while the research and development to revenue, 4.84%, highlights investment in innovation. The ratio of intangibles to total assets, 48.48%, indicates the value of non-physical assets, and capex to operating cash flow, -390.59%, measures reinvestment capability.

Enterprise Value386,363,740.85
Income Quality-0.05
Sales General and Administrative to Revenue0.25
Research and Development to Revenue4.84%
Intangibles to Total Assets48.48%
Capex to Operating Cash Flow-390.59%
Capex to Revenue-9.59%
Capex to Depreciation-93.67%
Stock-Based Compensation to Revenue12.30%
Graham Number12.97
Return on Tangible Assets-39.08%
Graham Net Net-14.04
Working Capital68,178,000
Tangible Asset Value-243,272,000
Net Current Asset Value-270,920,000
Invested Capital-6
Average Receivables40,468,500
Average Payables16,318,500
Average Inventory6,005,000
Days Sales Outstanding43
Days Payables Outstanding31
Days of Inventory On Hand10

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, -3.42, and the price to book ratio, -3.42, reflect the market's valuation relative to the company's book value. The price to sales ratio, 0.84, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -11.82, and price to operating cash flows, -52.03, gauge market valuation against cash flow metrics.

Price Book Value Ratio-3.42
Price to Book Ratio-3.42
Price to Sales Ratio0.84
Price Cash Flow Ratio-52.03
Price Earnings to Growth Ratio0.02
Enterprise Value Multiple-0.60
Price Fair Value-3.42
Price to Operating Cash Flow Ratio-52.03
Price to Free Cash Flows Ratio-11.82
Price to Tangible Book Ratio-2.11
Enterprise Value to Sales1.29
Enterprise Value Over EBITDA-15.68
EV to Operating Cash Flow52.52
Earnings Yield-64.31%
Free Cash Flow Yield-17.78%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Tabula Rasa HealthCare, Inc. (TRHC) on the NASDAQ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -4.363 in 2024.

What is the ticker symbol of Tabula Rasa HealthCare, Inc. stock?

The ticker symbol of Tabula Rasa HealthCare, Inc. stock is TRHC.

What is company IPO date?

IPO date of Tabula Rasa HealthCare, Inc. is 2016-09-29.

What is company current share price?

Current share price is 10.500 USD.

What is stock market cap today?

The market cap of stock today is 284033400.000.

What is PEG ratio in 2024?

The current 0.023 is 0.023 in 2024.

What is the number of employees in 2024?

In 2024 the company has 1027.